Page 52 - Sohini Das

Bharat Bio's nasal Covid vaccine to cost Rs 800/dose in private market

Price at Rs 325 per dose for large-volume government procurement, will be on sale late January

Kinetic to start producing electric version of Luna at Ahmednagar plant

Company set ups dedicated production line with an initial capacity of 5,000 sets per month

Advent International to pick up 50.1% in Suven Pharma for Rs 6,313 crore

To launch open offer for another 26%; plans merger with Cohance

We aim to be one of India's top CDMO, API players: Advent's Shweta Jalan

'Suven alone has multiple engines of growth across all segments and a strong pipeline of Phase 3 and late Phase 2 molecules'

Hyderabad-based drug major Hetero prices Paxlovid generic at $60 per course

Generic version of Pfizer's Covid antiviral treatment would be exported for $70

Pharma exports likely to touch all-time high of $27 bn in FY23 riding on EU

Better figure expected despite global headwinds; India has so far exported pharma products worth $16.57 bn during April-November this year

States start mock drills, get the beds and O2 ready to take on Covid

The airport tests are aimed at a 2 per cent sample of all incoming international travellers

States to conduct mock drills next week to review Covid preparedness

Specific focus on oxygen plants, ventilators, logistics and human resources; aim is to check whether the equipment is in running condition, or needs refurbishment

As Covid-19 cases fall, Indians drag feet to get their booster shots

Less than 30,000 booster doses daily in December, vaccine coverage flat for two months

Mask up, take the jab, Covid is not over yet, Centre cautions citizens

A new and highly transmissible BF.7 strain of the Omicron variant is behind a widespread surge of Covid infections in China

Maiden Pharma cough syrup row: Gambian Parliament seeks legal action

WHO, however, said samples tested in Ghana and Switzerland were found to be contaminated

As China cases surge, India must keep an eye on raw material supplies

Epidemiologist forecasts 10% of world population will be infected in next 90-days

Maiden Pharma seeks to reopen Sonipat plant after DCGI clearance

However, the DCGI has now said the cough syrups in question were found not to be contaminated, and met with government standards

WHO stands by action of issuing alert against Maiden Pharma cough syrup

Asserts that testing done in labs in Ghana and Switzerland confirmed excess levels of contaminated syrups that are "dangerous and should not be in any medicine, ever"

Maiden Pharma's cough syrups are safe, WHO jumped the gun: DCGI

'Irreparable damage' to Indian pharma's global image, drug regulator writes to WHO

Rising cost of raw materials a challenge for drug firms: Cipla's Hamied

Companies will have to manage work to match India's National List of Essential Medicines but it will be worth the endeavour, she says

M&M to invest Rs 10,000 cr to set up plant in Pune for upcoming EV range

Auto major aims to have 30% of its sales to be from electric vehicles by 2027

As India again reports Zika virus case, focus turns to vaccine, testing

Bharat Biotech's Zikavac now in clinical trial; labs look to offer Zika virus test

Eyestem to start first trial in India to treat age-related blindness

The first nine patients that they will inject would be legally blind, as they have to prove safety first

Drug regulators, pharma firms step up action on fake and substandard drugs

Detection of spurious and substandard drugs was up by 47% from 2020 to 2021, according to an ASPA Report